Experimental Weight-Loss Pill Twice as Effective as Ozempic, Trial Shows

An experimental new weight loss pill from Danish pharmaceutical giant Novo Nordisk could be twice as effective as its blockbuster Ozempic and Wegovy jabs, early results from a small trial have suggested, sending the firm's shares soaring. The drug amycretin caused people to lose 13 percent of…#danish #novonordisk #amycretin #glp1 #novonordiskeurope #ozempic #danieldrucker #newscientist #martinholstlange #cagrisema
Source: Reuters: Health - Category: Consumer Health News Source Type: news